Thu | Jul 9, 2026

Moderna, Japan partner recall 1.6 million vaccine doses

Published:Thursday | September 2, 2021 | 9:50 AM
In this June 14, 2021, file photo, a vital of the Moderna COVID-19 vaccine that is being administered for flight attendants of Japan Airlines at Haneda Airport as the airline company began its workplace vaccination, in Tokyo. Moderna Inc. and its Japanese partner are recalling more than one million doses of the US drug maker's coronavirus vaccine after confirming that contamination reported was tiny particles of stainless steel. (AP Photo/Eugene Hoshiko, File)

TOKYO — Moderna Inc. and its Japanese partner are recalling more than one million doses of the US drug maker's coronavirus vaccine after confirming that contamination reported last week was tiny particles of stainless steel.

Takeda Pharmaceutical Co. is in charge of the sale and distribution in Japan of the Moderna vaccine.

The two companies said an investigation at a Spanish factory that produced the vials in question concluded the contamination occurred in the process of putting stops on the vials.

The companies on August 26 announced the suspension of 1.63 million doses produced at the line after reports of contamination.

Japanese officials said about a half million people had received shots from the Moderna vials before the problem surfaced.

The trouble comes at a time Japan is pushing to accelerate vaccinations amid rising infections that are straining the Japanese health care system.

Pharmaceutical and health ministry officials say they do not believe the high-grade stainless steel poses health risks.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.